Tuberculosis drugs: new candidates and how to find more
- PMID: 21707310
- DOI: 10.2217/fmb.11.46
Tuberculosis drugs: new candidates and how to find more
Abstract
The recent years have witnessed significant progress in the development of new drug candidates for the treatment of TB. While many of these are now in clinical trials, continued research is needed in order to sustain the drug discovery pipeline and meet the increasing needs of TB patients. These include shortening treatment, killing drug-resistant strains, and finding medications compatible with antiretroviral and diabetes therapy. Nowadays, TB drug discovery benefits from high-throughput screening methods, availability of conditional expression systems, and biophysical and biochemical techniques that enable target-based rational drug design. This article reviews the current state of TB drug development and discusses possible approaches to finding new leads.
© 2011 Future Medicine Ltd
Similar articles
-
Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.Clin Chest Med. 2009 Dec;30(4):755-68, ix. doi: 10.1016/j.ccm.2009.08.011. Clin Chest Med. 2009. PMID: 19925965 Review.
-
New tuberculosis drugs on the horizon.Curr Opin Microbiol. 2011 Oct;14(5):570-6. doi: 10.1016/j.mib.2011.07.022. Epub 2011 Aug 5. Curr Opin Microbiol. 2011. PMID: 21821466 Review.
-
Rising standards for tuberculosis drug development.Trends Pharmacol Sci. 2008 Nov;29(11):576-81. doi: 10.1016/j.tips.2008.08.001. Epub 2008 Sep 15. Trends Pharmacol Sci. 2008. PMID: 18799223 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Anti-infectives: can cellular screening deliver?Curr Opin Chem Biol. 2011 Aug;15(4):529-33. doi: 10.1016/j.cbpa.2011.06.007. Epub 2011 Jun 30. Curr Opin Chem Biol. 2011. PMID: 21723774 Review.
Cited by
-
Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.Future Microbiol. 2013 Jul;8(7):855-75. doi: 10.2217/fmb.13.52. Future Microbiol. 2013. PMID: 23841633 Free PMC article. Review.
-
Learning from the past for TB drug discovery in the future.Drug Discov Today. 2017 Mar;22(3):534-545. doi: 10.1016/j.drudis.2016.09.025. Epub 2016 Oct 4. Drug Discov Today. 2017. PMID: 27717850 Free PMC article. Review.
-
Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.Biomed Res Int. 2015;2015:895453. doi: 10.1155/2015/895453. Epub 2015 Jan 8. Biomed Res Int. 2015. PMID: 25649791 Free PMC article. Review.
-
Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2014 May;58(5):2944-7. doi: 10.1128/AAC.02693-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550336 Free PMC article.
-
Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis.ACS Infect Dis. 2021 Jan 8;7(1):141-152. doi: 10.1021/acsinfecdis.0c00675. Epub 2020 Dec 15. ACS Infect Dis. 2021. PMID: 33319550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
